0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-inflammatory Therapy Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-6H14514
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Anti inflammatory Therapy Market Research Report 2023
BUY CHAPTERS

Global Anti-inflammatory Therapy Market Research Report 2025

Code: QYRE-Auto-6H14514
Report
July 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Anti-inflammatory Therapy Market Size

The global market for Anti-inflammatory Therapy was valued at US$ 124790 million in the year 2024 and is projected to reach a revised size of US$ 187790 million by 2031, growing at a CAGR of 6.1% during the forecast period.

Anti-inflammatory Therapy Market

Anti-inflammatory Therapy Market

Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Anti-inflammatory Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-inflammatory Therapy.
The Anti-inflammatory Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-inflammatory Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-inflammatory Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Anti-inflammatory Therapy Market Report

Report Metric Details
Report Name Anti-inflammatory Therapy Market
Accounted market size in year US$ 124790 million
Forecasted market size in 2031 US$ 187790 million
CAGR 6.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Corticosteroids
  • Anti-inflammatory Biologics
  • Non-Steroidal Anti-inflammatory Drugs
  • Others
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AbbVie, Johnson & Johnson, Amgen Inc, AstraZeneca PLC, Pfizer, Inc, Novartis, Roche, Merck, Sanofi, GlaxoSmithKline, Sun Pharmaceutical Industries Ltd, TEVA
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Anti-inflammatory Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Anti-inflammatory Therapy Market growing?

Ans: The Anti-inflammatory Therapy Market witnessing a CAGR of 6.1% during the forecast period 2025-2031.

What is the Anti-inflammatory Therapy Market size in 2031?

Ans: The Anti-inflammatory Therapy Market size in 2031 will be US$ 187790 million.

Who are the main players in the Anti-inflammatory Therapy Market report?

Ans: The main players in the Anti-inflammatory Therapy Market are AbbVie, Johnson & Johnson, Amgen Inc, AstraZeneca PLC, Pfizer, Inc, Novartis, Roche, Merck, Sanofi, GlaxoSmithKline, Sun Pharmaceutical Industries Ltd, TEVA

What are the Application segmentation covered in the Anti-inflammatory Therapy Market report?

Ans: The Applications covered in the Anti-inflammatory Therapy Market report are Respiratory Diseases, Arthritis, Gastroenterology, Dermatology, Others

What are the Type segmentation covered in the Anti-inflammatory Therapy Market report?

Ans: The Types covered in the Anti-inflammatory Therapy Market report are Corticosteroids, Anti-inflammatory Biologics, Non-Steroidal Anti-inflammatory Drugs, Others

Recommended Reports

Anti-inflammatory Drugs

Autoimmune & Arthritis

Therapy & Treatment

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-inflammatory Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Corticosteroids
1.2.3 Anti-inflammatory Biologics
1.2.4 Non-Steroidal Anti-inflammatory Drugs
1.2.5 Others
1.3 Market by Application
1.3.1 Global Anti-inflammatory Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Respiratory Diseases
1.3.3 Arthritis
1.3.4 Gastroenterology
1.3.5 Dermatology
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-inflammatory Therapy Market Perspective (2020-2031)
2.2 Global Anti-inflammatory Therapy Growth Trends by Region
2.2.1 Global Anti-inflammatory Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Anti-inflammatory Therapy Historic Market Size by Region (2020-2025)
2.2.3 Anti-inflammatory Therapy Forecasted Market Size by Region (2026-2031)
2.3 Anti-inflammatory Therapy Market Dynamics
2.3.1 Anti-inflammatory Therapy Industry Trends
2.3.2 Anti-inflammatory Therapy Market Drivers
2.3.3 Anti-inflammatory Therapy Market Challenges
2.3.4 Anti-inflammatory Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-inflammatory Therapy Players by Revenue
3.1.1 Global Top Anti-inflammatory Therapy Players by Revenue (2020-2025)
3.1.2 Global Anti-inflammatory Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Anti-inflammatory Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Anti-inflammatory Therapy Revenue
3.4 Global Anti-inflammatory Therapy Market Concentration Ratio
3.4.1 Global Anti-inflammatory Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-inflammatory Therapy Revenue in 2024
3.5 Global Key Players of Anti-inflammatory Therapy Head office and Area Served
3.6 Global Key Players of Anti-inflammatory Therapy, Product and Application
3.7 Global Key Players of Anti-inflammatory Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-inflammatory Therapy Breakdown Data by Type
4.1 Global Anti-inflammatory Therapy Historic Market Size by Type (2020-2025)
4.2 Global Anti-inflammatory Therapy Forecasted Market Size by Type (2026-2031)
5 Anti-inflammatory Therapy Breakdown Data by Application
5.1 Global Anti-inflammatory Therapy Historic Market Size by Application (2020-2025)
5.2 Global Anti-inflammatory Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Anti-inflammatory Therapy Market Size (2020-2031)
6.2 North America Anti-inflammatory Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Anti-inflammatory Therapy Market Size by Country (2020-2025)
6.4 North America Anti-inflammatory Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-inflammatory Therapy Market Size (2020-2031)
7.2 Europe Anti-inflammatory Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Anti-inflammatory Therapy Market Size by Country (2020-2025)
7.4 Europe Anti-inflammatory Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-inflammatory Therapy Market Size (2020-2031)
8.2 Asia-Pacific Anti-inflammatory Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Anti-inflammatory Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Anti-inflammatory Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-inflammatory Therapy Market Size (2020-2031)
9.2 Latin America Anti-inflammatory Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Anti-inflammatory Therapy Market Size by Country (2020-2025)
9.4 Latin America Anti-inflammatory Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-inflammatory Therapy Market Size (2020-2031)
10.2 Middle East & Africa Anti-inflammatory Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Anti-inflammatory Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Anti-inflammatory Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Anti-inflammatory Therapy Introduction
11.1.4 AbbVie Revenue in Anti-inflammatory Therapy Business (2020-2025)
11.1.5 AbbVie Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Anti-inflammatory Therapy Introduction
11.2.4 Johnson & Johnson Revenue in Anti-inflammatory Therapy Business (2020-2025)
11.2.5 Johnson & Johnson Recent Development
11.3 Amgen Inc
11.3.1 Amgen Inc Company Details
11.3.2 Amgen Inc Business Overview
11.3.3 Amgen Inc Anti-inflammatory Therapy Introduction
11.3.4 Amgen Inc Revenue in Anti-inflammatory Therapy Business (2020-2025)
11.3.5 Amgen Inc Recent Development
11.4 AstraZeneca PLC
11.4.1 AstraZeneca PLC Company Details
11.4.2 AstraZeneca PLC Business Overview
11.4.3 AstraZeneca PLC Anti-inflammatory Therapy Introduction
11.4.4 AstraZeneca PLC Revenue in Anti-inflammatory Therapy Business (2020-2025)
11.4.5 AstraZeneca PLC Recent Development
11.5 Pfizer, Inc
11.5.1 Pfizer, Inc Company Details
11.5.2 Pfizer, Inc Business Overview
11.5.3 Pfizer, Inc Anti-inflammatory Therapy Introduction
11.5.4 Pfizer, Inc Revenue in Anti-inflammatory Therapy Business (2020-2025)
11.5.5 Pfizer, Inc Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Anti-inflammatory Therapy Introduction
11.6.4 Novartis Revenue in Anti-inflammatory Therapy Business (2020-2025)
11.6.5 Novartis Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Anti-inflammatory Therapy Introduction
11.7.4 Roche Revenue in Anti-inflammatory Therapy Business (2020-2025)
11.7.5 Roche Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Anti-inflammatory Therapy Introduction
11.8.4 Merck Revenue in Anti-inflammatory Therapy Business (2020-2025)
11.8.5 Merck Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Anti-inflammatory Therapy Introduction
11.9.4 Sanofi Revenue in Anti-inflammatory Therapy Business (2020-2025)
11.9.5 Sanofi Recent Development
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Details
11.10.2 GlaxoSmithKline Business Overview
11.10.3 GlaxoSmithKline Anti-inflammatory Therapy Introduction
11.10.4 GlaxoSmithKline Revenue in Anti-inflammatory Therapy Business (2020-2025)
11.10.5 GlaxoSmithKline Recent Development
11.11 Sun Pharmaceutical Industries Ltd
11.11.1 Sun Pharmaceutical Industries Ltd Company Details
11.11.2 Sun Pharmaceutical Industries Ltd Business Overview
11.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapy Introduction
11.11.4 Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapy Business (2020-2025)
11.11.5 Sun Pharmaceutical Industries Ltd Recent Development
11.12 TEVA
11.12.1 TEVA Company Details
11.12.2 TEVA Business Overview
11.12.3 TEVA Anti-inflammatory Therapy Introduction
11.12.4 TEVA Revenue in Anti-inflammatory Therapy Business (2020-2025)
11.12.5 TEVA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Anti-inflammatory Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Corticosteroids
 Table 3. Key Players of Anti-inflammatory Biologics
 Table 4. Key Players of Non-Steroidal Anti-inflammatory Drugs
 Table 5. Key Players of Others
 Table 6. Global Anti-inflammatory Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Anti-inflammatory Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Anti-inflammatory Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Anti-inflammatory Therapy Market Share by Region (2020-2025)
 Table 10. Global Anti-inflammatory Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Anti-inflammatory Therapy Market Share by Region (2026-2031)
 Table 12. Anti-inflammatory Therapy Market Trends
 Table 13. Anti-inflammatory Therapy Market Drivers
 Table 14. Anti-inflammatory Therapy Market Challenges
 Table 15. Anti-inflammatory Therapy Market Restraints
 Table 16. Global Anti-inflammatory Therapy Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Anti-inflammatory Therapy Market Share by Players (2020-2025)
 Table 18. Global Top Anti-inflammatory Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-inflammatory Therapy as of 2024)
 Table 19. Ranking of Global Top Anti-inflammatory Therapy Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Anti-inflammatory Therapy Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Anti-inflammatory Therapy, Headquarters and Area Served
 Table 22. Global Key Players of Anti-inflammatory Therapy, Product and Application
 Table 23. Global Key Players of Anti-inflammatory Therapy, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Anti-inflammatory Therapy Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Anti-inflammatory Therapy Revenue Market Share by Type (2020-2025)
 Table 27. Global Anti-inflammatory Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Anti-inflammatory Therapy Revenue Market Share by Type (2026-2031)
 Table 29. Global Anti-inflammatory Therapy Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Anti-inflammatory Therapy Revenue Market Share by Application (2020-2025)
 Table 31. Global Anti-inflammatory Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Anti-inflammatory Therapy Revenue Market Share by Application (2026-2031)
 Table 33. North America Anti-inflammatory Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Anti-inflammatory Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Anti-inflammatory Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Anti-inflammatory Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Anti-inflammatory Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Anti-inflammatory Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Anti-inflammatory Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Anti-inflammatory Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Anti-inflammatory Therapy Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Anti-inflammatory Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Anti-inflammatory Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Anti-inflammatory Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Anti-inflammatory Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Anti-inflammatory Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Anti-inflammatory Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 48. AbbVie Company Details
 Table 49. AbbVie Business Overview
 Table 50. AbbVie Anti-inflammatory Therapy Product
 Table 51. AbbVie Revenue in Anti-inflammatory Therapy Business (2020-2025) & (US$ Million)
 Table 52. AbbVie Recent Development
 Table 53. Johnson & Johnson Company Details
 Table 54. Johnson & Johnson Business Overview
 Table 55. Johnson & Johnson Anti-inflammatory Therapy Product
 Table 56. Johnson & Johnson Revenue in Anti-inflammatory Therapy Business (2020-2025) & (US$ Million)
 Table 57. Johnson & Johnson Recent Development
 Table 58. Amgen Inc Company Details
 Table 59. Amgen Inc Business Overview
 Table 60. Amgen Inc Anti-inflammatory Therapy Product
 Table 61. Amgen Inc Revenue in Anti-inflammatory Therapy Business (2020-2025) & (US$ Million)
 Table 62. Amgen Inc Recent Development
 Table 63. AstraZeneca PLC Company Details
 Table 64. AstraZeneca PLC Business Overview
 Table 65. AstraZeneca PLC Anti-inflammatory Therapy Product
 Table 66. AstraZeneca PLC Revenue in Anti-inflammatory Therapy Business (2020-2025) & (US$ Million)
 Table 67. AstraZeneca PLC Recent Development
 Table 68. Pfizer, Inc Company Details
 Table 69. Pfizer, Inc Business Overview
 Table 70. Pfizer, Inc Anti-inflammatory Therapy Product
 Table 71. Pfizer, Inc Revenue in Anti-inflammatory Therapy Business (2020-2025) & (US$ Million)
 Table 72. Pfizer, Inc Recent Development
 Table 73. Novartis Company Details
 Table 74. Novartis Business Overview
 Table 75. Novartis Anti-inflammatory Therapy Product
 Table 76. Novartis Revenue in Anti-inflammatory Therapy Business (2020-2025) & (US$ Million)
 Table 77. Novartis Recent Development
 Table 78. Roche Company Details
 Table 79. Roche Business Overview
 Table 80. Roche Anti-inflammatory Therapy Product
 Table 81. Roche Revenue in Anti-inflammatory Therapy Business (2020-2025) & (US$ Million)
 Table 82. Roche Recent Development
 Table 83. Merck Company Details
 Table 84. Merck Business Overview
 Table 85. Merck Anti-inflammatory Therapy Product
 Table 86. Merck Revenue in Anti-inflammatory Therapy Business (2020-2025) & (US$ Million)
 Table 87. Merck Recent Development
 Table 88. Sanofi Company Details
 Table 89. Sanofi Business Overview
 Table 90. Sanofi Anti-inflammatory Therapy Product
 Table 91. Sanofi Revenue in Anti-inflammatory Therapy Business (2020-2025) & (US$ Million)
 Table 92. Sanofi Recent Development
 Table 93. GlaxoSmithKline Company Details
 Table 94. GlaxoSmithKline Business Overview
 Table 95. GlaxoSmithKline Anti-inflammatory Therapy Product
 Table 96. GlaxoSmithKline Revenue in Anti-inflammatory Therapy Business (2020-2025) & (US$ Million)
 Table 97. GlaxoSmithKline Recent Development
 Table 98. Sun Pharmaceutical Industries Ltd Company Details
 Table 99. Sun Pharmaceutical Industries Ltd Business Overview
 Table 100. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapy Product
 Table 101. Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapy Business (2020-2025) & (US$ Million)
 Table 102. Sun Pharmaceutical Industries Ltd Recent Development
 Table 103. TEVA Company Details
 Table 104. TEVA Business Overview
 Table 105. TEVA Anti-inflammatory Therapy Product
 Table 106. TEVA Revenue in Anti-inflammatory Therapy Business (2020-2025) & (US$ Million)
 Table 107. TEVA Recent Development
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Anti-inflammatory Therapy Picture
 Figure 2. Global Anti-inflammatory Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Anti-inflammatory Therapy Market Share by Type: 2024 VS 2031
 Figure 4. Corticosteroids Features
 Figure 5. Anti-inflammatory Biologics Features
 Figure 6. Non-Steroidal Anti-inflammatory Drugs Features
 Figure 7. Others Features
 Figure 8. Global Anti-inflammatory Therapy Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Anti-inflammatory Therapy Market Share by Application: 2024 VS 2031
 Figure 10. Respiratory Diseases Case Studies
 Figure 11. Arthritis Case Studies
 Figure 12. Gastroenterology Case Studies
 Figure 13. Dermatology Case Studies
 Figure 14. Others Case Studies
 Figure 15. Anti-inflammatory Therapy Report Years Considered
 Figure 16. Global Anti-inflammatory Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 17. Global Anti-inflammatory Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Anti-inflammatory Therapy Market Share by Region: 2024 VS 2031
 Figure 19. Global Anti-inflammatory Therapy Market Share by Players in 2024
 Figure 20. Global Top Anti-inflammatory Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-inflammatory Therapy as of 2024)
 Figure 21. The Top 10 and 5 Players Market Share by Anti-inflammatory Therapy Revenue in 2024
 Figure 22. North America Anti-inflammatory Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. North America Anti-inflammatory Therapy Market Share by Country (2020-2031)
 Figure 24. United States Anti-inflammatory Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Canada Anti-inflammatory Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Anti-inflammatory Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Anti-inflammatory Therapy Market Share by Country (2020-2031)
 Figure 28. Germany Anti-inflammatory Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. France Anti-inflammatory Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. U.K. Anti-inflammatory Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Italy Anti-inflammatory Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Russia Anti-inflammatory Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Nordic Countries Anti-inflammatory Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Anti-inflammatory Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Anti-inflammatory Therapy Market Share by Region (2020-2031)
 Figure 36. China Anti-inflammatory Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Japan Anti-inflammatory Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. South Korea Anti-inflammatory Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Anti-inflammatory Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. India Anti-inflammatory Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Australia Anti-inflammatory Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Anti-inflammatory Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Anti-inflammatory Therapy Market Share by Country (2020-2031)
 Figure 44. Mexico Anti-inflammatory Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Brazil Anti-inflammatory Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Anti-inflammatory Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Anti-inflammatory Therapy Market Share by Country (2020-2031)
 Figure 48. Turkey Anti-inflammatory Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Anti-inflammatory Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. UAE Anti-inflammatory Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. AbbVie Revenue Growth Rate in Anti-inflammatory Therapy Business (2020-2025)
 Figure 52. Johnson & Johnson Revenue Growth Rate in Anti-inflammatory Therapy Business (2020-2025)
 Figure 53. Amgen Inc Revenue Growth Rate in Anti-inflammatory Therapy Business (2020-2025)
 Figure 54. AstraZeneca PLC Revenue Growth Rate in Anti-inflammatory Therapy Business (2020-2025)
 Figure 55. Pfizer, Inc Revenue Growth Rate in Anti-inflammatory Therapy Business (2020-2025)
 Figure 56. Novartis Revenue Growth Rate in Anti-inflammatory Therapy Business (2020-2025)
 Figure 57. Roche Revenue Growth Rate in Anti-inflammatory Therapy Business (2020-2025)
 Figure 58. Merck Revenue Growth Rate in Anti-inflammatory Therapy Business (2020-2025)
 Figure 59. Sanofi Revenue Growth Rate in Anti-inflammatory Therapy Business (2020-2025)
 Figure 60. GlaxoSmithKline Revenue Growth Rate in Anti-inflammatory Therapy Business (2020-2025)
 Figure 61. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Anti-inflammatory Therapy Business (2020-2025)
 Figure 62. TEVA Revenue Growth Rate in Anti-inflammatory Therapy Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS